Afaxys Candid Conversations in Public Health
Join Afaxys—a Public Benefit Corporation serving public health clinicians and their patients—for Candid Conversations in Public Health, a podcast series exploring today’s most pressing issues in sexual and reproductive healthcare.
Each episode takes you to the front lines with timely discussions and practical insights from leading experts, clinicians, and innovators. From STI clinical care and contraceptive access to emerging challenges and policy shifts, these candid conversations highlight the realities and future of public health.
Whether you’re a clinician, healthcare leader, or simply interested in how public health is evolving, this series offers relevant, accessible, and meaningful dialogue to inform and inspire your work.
Learn more about Afaxys and our resources for clinicians at Afaxys.com.
Afaxys Candid Conversations in Public Health
On the Front Lines of Bacterial Vaginosis Treatment: New ACOG Partner Treatment Recommendations
In our fifth episode of Afaxys Candid Conversations in Public Health, we discuss the recently published “StepUp” randomized controlled trial of male partner treatment for the prevention of bacterial vaginosis (BV) recurrence in female partners with our expert guests, Dr. Craig Cohen and Dr. Ina Park. Building on our previous episode 4, part 2, we take a deep dive into the American College of Obstetricians and Gynecologists Clinical Practice Update: Concurrent Sexual Partner Therapy to Prevent Bacterial Vaginosis Recurrence. This guidance was based on the StepUp clinical trial and published after we spoke with Dr. Christina Muzny in our last episode.
Today’s discussion covers why the vaginal microbiome is central to BV, what the recent clinical trial from Australia actually showed, a critical look at the new clinical practice update, and why applying the Australian trial findings in U.S. clinics requires appreciation of the nuances of the trial population. Our experts also explore whether BV should be viewed as a sexually transmitted infection, plus the practical challenges of treating male partners. They also highlight emerging strategies—such as microbiome-restoring therapies—and key questions that still need research before widespread adoption.
Disclosures:
Dr. Cohen discloses that he is on the scientific committee for Osel and Evvy.
Dr. Park has no disclosures.
Resources:
***Free CME!*** STI Expert Hour Webinar - Male Partner Treatment to Prevent BV Recurrence: Evidence and Implementation on December 18, 2025
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Bacterial Vaginosis — Time to Treat Male Partners
ACOG PUBLICATIONS: CLINICAL PRACTICE UPDATE
Concurrent Sexual Partner Therapy to Prevent Bacterial Vaginosis Recurrence
Melbourne Sexual Health Centre - BV in focus
Educational content only — not a substitute for professional medical advice. Opinions are those of the speakers and not necessarily of Afaxys. Visit Afaxys.com for resources.